The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
Related Posts
Dick’s Sporting Goods forecasts annual sales above estimates on steady demand
March 12 (Reuters) – Dick’s Sporting Goods on Thursday forecast its annual sales above Wall Street expectations after topping quarterly…
Frontier markets fail to live up to economic potential, says World Bank
LONDON, Jan 20 (Reuters) – Frontier market economies have failed to live up to their potential in recent decades, suffering…
Netflix to buy Warner Bros Discovery’s studios, streaming unit for $72 billion
By Harshita Mary Varghese and Aditya Soni Dec 5 (Reuters) – Netflix on Friday agreed to buy Warner Bros Discovery’s…